Global Anti-obesity Medicine Market Growth (Status and Outlook) 2024-2031

Report ID: 1289779 | Published Date: Jan 2025 | No. of Page: 104 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Anti-obesity Medicine Market Size 2017-2028
        2.1.2 Anti-obesity Medicine Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Anti-obesity Medicine Segment by Type
        2.2.1 Prescription Drugs
        2.2.2 OTC Drugs
    2.3 Anti-obesity Medicine Market Size by Type
        2.3.1 Anti-obesity Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Anti-obesity Medicine Market Size Market Share by Type (2017-2022)
    2.4 Anti-obesity Medicine Segment by Application
        2.4.1 Men
        2.4.2 Women
    2.5 Anti-obesity Medicine Market Size by Application
        2.5.1 Anti-obesity Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Anti-obesity Medicine Market Size Market Share by Application (2017-2022)
3 Anti-obesity Medicine Market Size by Player
    3.1 Anti-obesity Medicine Market Size Market Share by Players
        3.1.1 Global Anti-obesity Medicine Revenue by Players (2020-2022)
        3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2020-2022)
    3.2 Global Anti-obesity Medicine Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Anti-obesity Medicine by Regions
    4.1 Anti-obesity Medicine Market Size by Regions (2017-2022)
    4.2 Americas Anti-obesity Medicine Market Size Growth (2017-2022)
    4.3 APAC Anti-obesity Medicine Market Size Growth (2017-2022)
    4.4 Europe Anti-obesity Medicine Market Size Growth (2017-2022)
    4.5 Middle East & Africa Anti-obesity Medicine Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Anti-obesity Medicine Market Size by Country (2017-2022)
    5.2 Americas Anti-obesity Medicine Market Size by Type (2017-2022)
    5.3 Americas Anti-obesity Medicine Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Anti-obesity Medicine Market Size by Region (2017-2022)
    6.2 APAC Anti-obesity Medicine Market Size by Type (2017-2022)
    6.3 APAC Anti-obesity Medicine Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Anti-obesity Medicine by Country (2017-2022)
    7.2 Europe Anti-obesity Medicine Market Size by Type (2017-2022)
    7.3 Europe Anti-obesity Medicine Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Anti-obesity Medicine by Region (2017-2022)
    8.2 Middle East & Africa Anti-obesity Medicine Market Size by Type (2017-2022)
    8.3 Middle East & Africa Anti-obesity Medicine Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Anti-obesity Medicine Market Forecast
    10.1 Global Anti-obesity Medicine Forecast by Regions (2023-2028)
        10.1.1 Global Anti-obesity Medicine Forecast by Regions (2023-2028)
        10.1.2 Americas Anti-obesity Medicine Forecast
        10.1.3 APAC Anti-obesity Medicine Forecast
        10.1.4 Europe Anti-obesity Medicine Forecast
        10.1.5 Middle East & Africa Anti-obesity Medicine Forecast
    10.2 Americas Anti-obesity Medicine Forecast by Country (2023-2028)
        10.2.1 United States Anti-obesity Medicine Market Forecast
        10.2.2 Canada Anti-obesity Medicine Market Forecast
        10.2.3 Mexico Anti-obesity Medicine Market Forecast
        10.2.4 Brazil Anti-obesity Medicine Market Forecast
    10.3 APAC Anti-obesity Medicine Forecast by Region (2023-2028)
        10.3.1 China Anti-obesity Medicine Market Forecast
        10.3.2 Japan Anti-obesity Medicine Market Forecast
        10.3.3 Korea Anti-obesity Medicine Market Forecast
        10.3.4 Southeast Asia Anti-obesity Medicine Market Forecast
        10.3.5 India Anti-obesity Medicine Market Forecast
        10.3.6 Australia Anti-obesity Medicine Market Forecast
    10.4 Europe Anti-obesity Medicine Forecast by Country (2023-2028)
        10.4.1 Germany Anti-obesity Medicine Market Forecast
        10.4.2 France Anti-obesity Medicine Market Forecast
        10.4.3 UK Anti-obesity Medicine Market Forecast
        10.4.4 Italy Anti-obesity Medicine Market Forecast
        10.4.5 Russia Anti-obesity Medicine Market Forecast
    10.5 Middle East & Africa Anti-obesity Medicine Forecast by Region (2023-2028)
        10.5.1 Egypt Anti-obesity Medicine Market Forecast
        10.5.2 South Africa Anti-obesity Medicine Market Forecast
        10.5.3 Israel Anti-obesity Medicine Market Forecast
        10.5.4 Turkey Anti-obesity Medicine Market Forecast
        10.5.5 GCC Countries Anti-obesity Medicine Market Forecast
    10.6 Global Anti-obesity Medicine Forecast by Type (2023-2028)
    10.7 Global Anti-obesity Medicine Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Alizyme
        11.1.1 Alizyme Company Information
        11.1.2 Alizyme Anti-obesity Medicine Product Offered
        11.1.3 Alizyme Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Alizyme Main Business Overview
        11.1.5 Alizyme Latest Developments
    11.2 Amylin Pharmaceuticals
        11.2.1 Amylin Pharmaceuticals Company Information
        11.2.2 Amylin Pharmaceuticals Anti-obesity Medicine Product Offered
        11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Amylin Pharmaceuticals Main Business Overview
        11.2.5 Amylin Pharmaceuticals Latest Developments
    11.3 Arena Pharmaceuticals
        11.3.1 Arena Pharmaceuticals Company Information
        11.3.2 Arena Pharmaceuticals Anti-obesity Medicine Product Offered
        11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Arena Pharmaceuticals Main Business Overview
        11.3.5 Arena Pharmaceuticals Latest Developments
    11.4 Boehringer Ingelheim
        11.4.1 Boehringer Ingelheim Company Information
        11.4.2 Boehringer Ingelheim Anti-obesity Medicine Product Offered
        11.4.3 Boehringer Ingelheim Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Boehringer Ingelheim Main Business Overview
        11.4.5 Boehringer Ingelheim Latest Developments
    11.5 Eisai
        11.5.1 Eisai Company Information
        11.5.2 Eisai Anti-obesity Medicine Product Offered
        11.5.3 Eisai Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Eisai Main Business Overview
        11.5.5 Eisai Latest Developments
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Company Information
        11.6.2 GlaxoSmithKline Anti-obesity Medicine Product Offered
        11.6.3 GlaxoSmithKline Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 GlaxoSmithKline Main Business Overview
        11.6.5 GlaxoSmithKline Latest Developments
    11.7 Orexigen Therapeutics
        11.7.1 Orexigen Therapeutics Company Information
        11.7.2 Orexigen Therapeutics Anti-obesity Medicine Product Offered
        11.7.3 Orexigen Therapeutics Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Orexigen Therapeutics Main Business Overview
        11.7.5 Orexigen Therapeutics Latest Developments
    11.8 Vivus
        11.8.1 Vivus Company Information
        11.8.2 Vivus Anti-obesity Medicine Product Offered
        11.8.3 Vivus Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Vivus Main Business Overview
        11.8.5 Vivus Latest Developments
    11.9 Pfizer
        11.9.1 Pfizer Company Information
        11.9.2 Pfizer Anti-obesity Medicine Product Offered
        11.9.3 Pfizer Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Pfizer Main Business Overview
        11.9.5 Pfizer Latest Developments
    11.10 Roche
        11.10.1 Roche Company Information
        11.10.2 Roche Anti-obesity Medicine Product Offered
        11.10.3 Roche Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Roche Main Business Overview
        11.10.5 Roche Latest Developments
    11.11 Merck
        11.11.1 Merck Company Information
        11.11.2 Merck Anti-obesity Medicine Product Offered
        11.11.3 Merck Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Merck Main Business Overview
        11.11.5 Merck Latest Developments
    11.12 Novo Nordisk
        11.12.1 Novo Nordisk Company Information
        11.12.2 Novo Nordisk Anti-obesity Medicine Product Offered
        11.12.3 Novo Nordisk Anti-obesity Medicine Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Novo Nordisk Main Business Overview
        11.12.5 Novo Nordisk Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Anti-obesity Medicine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Prescription Drugs
    Table 3. Major Players of OTC Drugs
    Table 4. Anti-obesity Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 5. Global Anti-obesity Medicine Market Size by Type (2017-2022) & ($ Millions)
    Table 6. Global Anti-obesity Medicine Market Size Market Share by Type (2017-2022)
    Table 7. Anti-obesity Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Anti-obesity Medicine Market Size by Application (2017-2022) & ($ Millions)
    Table 9. Global Anti-obesity Medicine Market Size Market Share by Application (2017-2022)
    Table 10. Global Anti-obesity Medicine Revenue by Players (2020-2022) & ($ Millions)
    Table 11. Global Anti-obesity Medicine Revenue Market Share by Player (2020-2022)
    Table 12. Anti-obesity Medicine Key Players Head office and Products Offered
    Table 13. Anti-obesity Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 14. New Products and Potential Entrants
    Table 15. Mergers & Acquisitions, Expansion
    Table 16. Global Anti-obesity Medicine Market Size by Regions 2017-2022 & ($ Millions)
    Table 17. Global Anti-obesity Medicine Market Size Market Share by Regions (2017-2022)
    Table 18. Americas Anti-obesity Medicine Market Size by Country (2017-2022) & ($ Millions)
    Table 19. Americas Anti-obesity Medicine Market Size Market Share by Country (2017-2022)
    Table 20. Americas Anti-obesity Medicine Market Size by Type (2017-2022) & ($ Millions)
    Table 21. Americas Anti-obesity Medicine Market Size Market Share by Type (2017-2022)
    Table 22. Americas Anti-obesity Medicine Market Size by Application (2017-2022) & ($ Millions)
    Table 23. Americas Anti-obesity Medicine Market Size Market Share by Application (2017-2022)
    Table 24. APAC Anti-obesity Medicine Market Size by Region (2017-2022) & ($ Millions)
    Table 25. APAC Anti-obesity Medicine Market Size Market Share by Region (2017-2022)
    Table 26. APAC Anti-obesity Medicine Market Size by Type (2017-2022) & ($ Millions)
    Table 27. APAC Anti-obesity Medicine Market Size Market Share by Type (2017-2022)
    Table 28. APAC Anti-obesity Medicine Market Size by Application (2017-2022) & ($ Millions)
    Table 29. APAC Anti-obesity Medicine Market Size Market Share by Application (2017-2022)
    Table 30. Europe Anti-obesity Medicine Market Size by Country (2017-2022) & ($ Millions)
    Table 31. Europe Anti-obesity Medicine Market Size Market Share by Country (2017-2022)
    Table 32. Europe Anti-obesity Medicine Market Size by Type (2017-2022) & ($ Millions)
    Table 33. Europe Anti-obesity Medicine Market Size Market Share by Type (2017-2022)
    Table 34. Europe Anti-obesity Medicine Market Size by Application (2017-2022) & ($ Millions)
    Table 35. Europe Anti-obesity Medicine Market Size Market Share by Application (2017-2022)
    Table 36. Middle East & Africa Anti-obesity Medicine Market Size by Region (2017-2022) & ($ Millions)
    Table 37. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Region (2017-2022)
    Table 38. Middle East & Africa Anti-obesity Medicine Market Size by Type (2017-2022) & ($ Millions)
    Table 39. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Type (2017-2022)
    Table 40. Middle East & Africa Anti-obesity Medicine Market Size by Application (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Application (2017-2022)
    Table 42. Key Market Drivers & Growth Opportunities of Anti-obesity Medicine
    Table 43. Key Market Challenges & Risks of Anti-obesity Medicine
    Table 44. Key Industry Trends of Anti-obesity Medicine
    Table 45. Global Anti-obesity Medicine Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 46. Global Anti-obesity Medicine Market Size Market Share Forecast by Regions (2023-2028)
    Table 47. Global Anti-obesity Medicine Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 48. Global Anti-obesity Medicine Market Size Market Share Forecast by Type (2023-2028)
    Table 49. Global Anti-obesity Medicine Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 50. Global Anti-obesity Medicine Market Size Market Share Forecast by Application (2023-2028)
    Table 51. Alizyme Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 52. Alizyme Anti-obesity Medicine Product Offered
    Table 53. Alizyme Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 54. Alizyme Main Business
    Table 55. Alizyme Latest Developments
    Table 56. Amylin Pharmaceuticals Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 57. Amylin Pharmaceuticals Anti-obesity Medicine Product Offered
    Table 58. Amylin Pharmaceuticals Main Business
    Table 59. Amylin Pharmaceuticals Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 60. Amylin Pharmaceuticals Latest Developments
    Table 61. Arena Pharmaceuticals Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 62. Arena Pharmaceuticals Anti-obesity Medicine Product Offered
    Table 63. Arena Pharmaceuticals Main Business
    Table 64. Arena Pharmaceuticals Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 65. Arena Pharmaceuticals Latest Developments
    Table 66. Boehringer Ingelheim Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 67. Boehringer Ingelheim Anti-obesity Medicine Product Offered
    Table 68. Boehringer Ingelheim Main Business
    Table 69. Boehringer Ingelheim Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 70. Boehringer Ingelheim Latest Developments
    Table 71. Eisai Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 72. Eisai Anti-obesity Medicine Product Offered
    Table 73. Eisai Main Business
    Table 74. Eisai Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 75. Eisai Latest Developments
    Table 76. GlaxoSmithKline Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 77. GlaxoSmithKline Anti-obesity Medicine Product Offered
    Table 78. GlaxoSmithKline Main Business
    Table 79. GlaxoSmithKline Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 80. GlaxoSmithKline Latest Developments
    Table 81. Orexigen Therapeutics Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 82. Orexigen Therapeutics Anti-obesity Medicine Product Offered
    Table 83. Orexigen Therapeutics Main Business
    Table 84. Orexigen Therapeutics Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 85. Orexigen Therapeutics Latest Developments
    Table 86. Vivus Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 87. Vivus Anti-obesity Medicine Product Offered
    Table 88. Vivus Main Business
    Table 89. Vivus Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 90. Vivus Latest Developments
    Table 91. Pfizer Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 92. Pfizer Anti-obesity Medicine Product Offered
    Table 93. Pfizer Main Business
    Table 94. Pfizer Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 95. Pfizer Latest Developments
    Table 96. Roche Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 97. Roche Anti-obesity Medicine Product Offered
    Table 98. Roche Main Business
    Table 99. Roche Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 100. Roche Latest Developments
    Table 101. Merck Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 102. Merck Anti-obesity Medicine Product Offered
    Table 103. Merck Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 104. Merck Main Business
    Table 105. Merck Latest Developments
    Table 106. Novo Nordisk Details, Company Type, Anti-obesity Medicine Area Served and Its Competitors
    Table 107. Novo Nordisk Anti-obesity Medicine Product Offered
    Table 108. Novo Nordisk Main Business
    Table 109. Novo Nordisk Anti-obesity Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 110. Novo Nordisk Latest Developments
List of Figures
    Figure 1. Anti-obesity Medicine Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Anti-obesity Medicine Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Anti-obesity Medicine Market Size Market Share by Type in 2021
    Figure 7. Anti-obesity Medicine in Men
    Figure 8. Global Anti-obesity Medicine Market: Men (2017-2022) & ($ Millions)
    Figure 9. Anti-obesity Medicine in Women
    Figure 10. Global Anti-obesity Medicine Market: Women (2017-2022) & ($ Millions)
    Figure 11. Global Anti-obesity Medicine Market Size Market Share by Application in 2021
    Figure 12. Global Anti-obesity Medicine Revenue Market Share by Player in 2021
    Figure 13. Global Anti-obesity Medicine Market Size Market Share by Regions (2017-2022)
    Figure 14. Americas Anti-obesity Medicine Market Size 2017-2022 ($ Millions)
    Figure 15. APAC Anti-obesity Medicine Market Size 2017-2022 ($ Millions)
    Figure 16. Europe Anti-obesity Medicine Market Size 2017-2022 ($ Millions)
    Figure 17. Middle East & Africa Anti-obesity Medicine Market Size 2017-2022 ($ Millions)
    Figure 18. Americas Anti-obesity Medicine Value Market Share by Country in 2021
    Figure 19. Americas Anti-obesity Medicine Consumption Market Share by Type in 2021
    Figure 20. Americas Anti-obesity Medicine Market Size Market Share by Application in 2021
    Figure 21. United States Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 22. Canada Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 23. Mexico Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Brazil Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 25. APAC Anti-obesity Medicine Market Size Market Share by Region in 2021
    Figure 26. APAC Anti-obesity Medicine Market Size Market Share by Application in 2021
    Figure 27. China Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Japan Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 29. Korea Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Southeast Asia Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 31. India Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Australia Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Europe Anti-obesity Medicine Market Size Market Share by Country in 2021
    Figure 34. Europe Anti-obesity Medicine Market Size Market Share by Type in 2021
    Figure 35. Europe Anti-obesity Medicine Market Size Market Share by Application in 2021
    Figure 36. Germany Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 37. France Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 38. UK Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Italy Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Russia Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Region in 2021
    Figure 42. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Type in 2021
    Figure 43. Middle East & Africa Anti-obesity Medicine Market Size Market Share by Application in 2021
    Figure 44. Egypt Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 45. South Africa Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Israel Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Turkey Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 48. GCC Country Anti-obesity Medicine Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Americas Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 50. APAC Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 51. Europe Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 52. Middle East & Africa Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 53. United States Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 54. Canada Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 55. Mexico Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 56. Brazil Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 57. China Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 58. Japan Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 59. Korea Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 60. Southeast Asia Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 61. India Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 62. Australia Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 63. Germany Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 64. France Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 65. UK Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 66. Italy Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 67. Russia Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 68. Spain Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 69. Egypt Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 70. South Africa Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 71. Israel Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 72. Turkey Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
    Figure 73. GCC Countries Anti-obesity Medicine Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Anti-obesity Medicine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Anti-obesity Medicine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Anti-obesity Medicine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports